Skip to content
Top Globe News – Lifestyle
Author:
Jasper Therapeutics, Inc.
Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy
October 15, 2026
Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
October 7, 2026
Jasper Therapeutics Announces Key Regulatory and Clinical Appointments
September 15, 2026
Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 9, 2026
Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 14, 2026
Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
June 1, 2026
Jasper Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 14, 2026